Algarni Abdulrahman
Department of Medical Laboratory Technology, Faculty of Applied Medical Sciences, Northern Border University, Arar, SAU.
Cureus. 2024 Aug 21;16(8):e67421. doi: 10.7759/cureus.67421. eCollection 2024 Aug.
As per the Global Cancer Observatory, the WHO Eastern Mediterranean region (which includes the Arabic countries) ranks highest for age-standardized mortality rate at 4 per 100,000, thus indicating a probable role of genetic associations. Identifying the genes associated with leukemia in the Arab population is crucial for effective preventive and treatment strategies. This scoping review aimed to determine the nature and extent of research available on the genes associated with the major types of leukemia among the Arab population. As per the scoping review guidelines, a comprehensive search was conducted in PUBMED and Google Scholar for articles published before 01/10/2023 and focused on leukemia-related genes among the Arab population. In total 119 studies, focusing on genes associated with leukemia met the inclusion criteria. On reviewing these studies, 27 genes were found to be associated with ALL, 33 genes with AML, seven genes with CLL, and 14 genes with CML. The majority of these genes were associated with an increased risk for the disease. Notably, the 119 studies covered only nine out of the 22 Arab countries, with 56 studies carried out in Egypt, exhibiting an imbalance in the regional distribution of the research landscape. Thus, indicating the inadequacy of research on leukemia genetics in the Arab region in comparison to the Western studies. This finding highlights the need for extensive research in the Middle Eastern region to gain geographically heterogeneous genetic information about the Arab population. In conclusion, this scoping study highlights the genes associated with the major types of leukemia among the Arab population and also indicates the need for comprehensive and regionally balanced research on leukemia genetics in Middle Eastern countries. Addressing this gap is essential to provide robust genetic data that can be used for targeted interventions to improve leukemia outcomes in the Middle East. Increased research efforts in all Middle Eastern countries will contribute to a greater understanding of genetic predisposition and help develop effective prevention strategies and treatments tailored to this population.
根据全球癌症观测站的数据,世界卫生组织东地中海区域(包括阿拉伯国家)的年龄标准化死亡率最高,为每10万人中有4人,这表明基因关联可能起到了作用。确定阿拉伯人群中与白血病相关的基因对于有效的预防和治疗策略至关重要。本范围综述旨在确定阿拉伯人群中与主要类型白血病相关的已有研究的性质和范围。根据范围综述指南,在PUBMED和谷歌学术上对2023年10月1日之前发表的文章进行了全面搜索,重点关注阿拉伯人群中与白血病相关的基因。共有119项关注与白血病相关基因的研究符合纳入标准。在审查这些研究时,发现27个基因与急性淋巴细胞白血病(ALL)相关,33个基因与急性髓细胞白血病(AML)相关,7个基因与慢性淋巴细胞白血病(CLL)相关,14个基因与慢性髓细胞白血病(CML)相关。这些基因中的大多数与疾病风险增加相关。值得注意的是,这119项研究仅涵盖了22个阿拉伯国家中的9个,其中56项研究在埃及进行,研究格局的区域分布存在不平衡。因此,与西方研究相比,这表明阿拉伯地区白血病遗传学研究不足。这一发现凸显了在中东地区进行广泛研究以获取关于阿拉伯人群地理异质性遗传信息的必要性。总之,这项范围研究突出了阿拉伯人群中与主要类型白血病相关的基因,也表明了中东国家对白血病遗传学进行全面和区域平衡研究的必要性。弥补这一差距对于提供可用于针对性干预以改善中东白血病治疗效果的可靠遗传数据至关重要。所有中东国家加大研究力度将有助于更好地理解遗传易感性,并有助于制定针对该人群的有效预防策略和治疗方法。